ACTION ALERT: Contact your Senators and ask them to continue supporting the Scleroderma Peer-Reviewed Medical Research Program during the appropriations process for Fiscal Year (FY) 2022.
BACKGROUND: Currently, there is a $5 million Scleroderma Peer-Reviewed Medical Research Program at the Department of Defense for continued research into scleroderma. There is a strong connection between environmental exposures and the onset of autoimmune diseases, which leaves military personnel at risk for developing conditions like scleroderma. Further, scleroderma impacts military personnel because the scarring associated with the disease process has broad applications to combat injuries. We ask that Congress continue to support Scleroderma Peer-Reviewed Medical Research Program at the Department of Defense.
Senators are currently working on the final FY 2022 Dept. of Defense appropriations bill and deciding what final funding levels will be. At this critical juncture, please reach out to the Washington, DC offices of your Senators and ask that they “support funding for the Scleroderma Peer-Reviewed Research Program at $5 million in the final DoD FY 2022 bill.”
ACTION: Enter your contact information in the fields below to send a message to both of your Senators asking them to support funding for the Scleroderma Peer-Reviewed Research Program.
If you take action and have not already registered, you will receive periodic updates and communications from National Scleroderma Foundation.
Dear [Decision Maker],
Thank you for your leadership on patient care and public health issues. I write you today on behalf of the community of individuals affected by scleroderma to ask that you work with your colleagues to ensure that the Scleroderma Peer-Reviewed Research Program is again funded at $5 million as part of the final Defense Appropriations bill.
Sincerely,[Your Name] [Your Address] [City, State ZIP][Your Email]
National Scleroderma Foundation300 Rosewood DriveSuite 105Danvers, MA 01923
(800) 722-HOPE 
About The Foundation
Mission, Vision, Values
IRS Form 990
Media & News
©2022 National Scleroderma Foundation